Researchers are advancing the understanding of how gene mutations can lead to profound autism. Using lab-grown brain organoids, scientists probe critical protein interactions that might be associated with autism. This research offers hope for developing new treatments. A team at UC San Francisco mapped over a thousand protein interactions from autism risk genes. Their findings,...
The Food and Drug Administration (FDA) has approved a blood test intended to assist in diagnosing Alzheimer’s disease, with its release expected later this year. This test, named PrecivityAD2, is developed by C2N Diagnostics and targets adults 40 years and older exhibiting signs or symptoms of cognitive impairment. The test will complement clinical evaluations, aiding...
A recent study highlights a potential connection between popular weight-loss medications and male-pattern baldness. Researchers at NYU Langone Health indicate that GLP-1 drugs such as Ozempic, Wegovy, and Zepbound might exacerbate hair loss in men with a genetic predisposition to baldness. This study marks the first instance of genetic evidence associating GLP-1 activity with androgenetic...
A recent clinical trial revealed encouraging results for patients with advanced non-small-cell lung cancer. The trial indicated that one-third of participants experienced a reduction in tumor size after receiving the treatment. This trial, conducted on patients with advanced stages of the disease, involved individuals who had previously undergone standard cancer therapies, including chemotherapy. These early...
A group of researchers, led by scientists at the University of California, Berkeley, has discovered a promising oral compound called TOFA that has led to significant weight loss in obese mice, according to a study published in Science Advances. Unlike other treatments that suppress appetite, TOFA appears to increase energy expenditure in the body. TOFA’s...
An unexpected discovery during a routine medical appointment has highlighted the importance of regular health checkups. Andrea Pugh-Kelley, 31, an environmental scientist from Tallahassee, Florida, was diagnosed with a rare form of thyroid cancer known as Hurthle cell carcinoma. This condition was identified during a routine visit to her gynecologist, who conducted a thorough examination...
A brain scan tool designed to measure shrinkage in regions linked to thinking and memory may predict the rate at which individuals with early-onset Alzheimer’s progress from mild cognitive impairment (MCI) to dementia. Early-onset Alzheimer’s appears before age 65 and often starts with MCI, where memory and thinking issues are evident but not severe enough...
GSK’s cancer drug, Jemperli, has been granted priority review by the U.S. Food and Drug Administration (FDA) following promising results from a pivotal trial. The trial demonstrated that a significant proportion of patients with rectal tumors had no detectable signs of cancer for at least one year after treatment. If approved, the drug could transform...
Intermittent fasting has become a popular method for weight loss. Recent research suggests it might also help manage chronic pain by changing the gut-brain connection. A study published in the journal Brain, Behavior, and Immunity showed that meal timing impacts this relationship between the gut and the brain. Health institutions define intermittent fasting as a...
Recent research highlights that many commonly prescribed medications can cause enduring changes in the gut microbiome. A study analyzed stool samples from over 2,500 people at the Estonian Biobank, along with their prescription records and data from the Estonian Microbiome cohort. The study aimed to determine if medication use is linked to variations in the...